Riehl melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa. relevance score : -100.0%
References Riehl Melanosis 32491369 NIH
Riehl melanosis nthawi zambiri imadziwika kuti pigmented contact dermatitis. Ndi mtundu wa khungu lomwe limayamba chifukwa cha kusagwirizana ndi zinthu zina, zomwe nthawi zambiri zimayamba chifukwa cha fungo labwino komanso zinthu zina zopezeka muzodzikongoletsera. Ngakhale kuti amatchulidwa ngati mtundu wa dermatitis, Riehl melanosis imasonyeza kusintha kwa mtundu pakhungu, ndi zizindikiro zochepa chabe za kukwiya. Ndizofala kwambiri mwa anthu omwe ali ndi khungu lakuda. Kafukufuku waposachedwa wawona mphamvu ya mid-fluence QSNY 1064-nm chithandizo cha laser pothana ndi kuzama kwa pigmentation komwe kumalumikizidwa ndi Riehl melanosis. Kafukufuku wina anaphatikiza mankhwala osiyanasiyana, kuphatikizapo low-fluence 1064-nm Q-switched Nd: YAG laser, hydroquinone cream, ndi oral tranexamic acid, zomwe zimapangitsa kuti odwala ambiri apite patsogolo.
Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
Research Advances in the Treatment of Riehl’s Melanosis 37168093 NIH
Riehl's melanosis ndi mtundu wa khungu lomwe limayamba chifukwa chokhudzana ndi zinthu zina zosagwirizana ndi thupi komanso kukhala padzuwa. Zimapangitsa kuti khungu likhale lachangu, lotuwa-bulauni, lomwe lingakhudze kwambiri odwala m'maganizo ndi m'thupi. Ngakhale chomwe chimayambitsa Riehl's melanosis sichidziwikabe, kafukufuku omwe alipo akuwonetsa kugwirizana kwakukulu ndi kuwonetseredwa kwa allergen. Pochiza, mankhwala achikhalidwe komanso laser therapy ayesedwa, nthawi zambiri limodzi ndi kugwiritsa ntchito ma bleaching agents omwe amapaka pakhungu. Laser therapy, makamaka pogwiritsa ntchito Q-switched Nd:YAG laser, yawonetsa zotsatira zabwino zochizira Riehl's melanosis. Kuphatikiza njira zosiyanasiyana zochiritsira zadzetsa zotsatira zabwino.
Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.